280 related articles for article (PubMed ID: 38028589)
1. Circulating tumor cells participate in the formation of microvascular invasion and impact on clinical outcomes in hepatocellular carcinoma.
Sun B; Ji WD; Wang WC; Chen L; Ma JY; Tang EJ; Lin MB; Zhang XF
Front Genet; 2023; 14():1265866. PubMed ID: 38028589
[TBL] [Abstract][Full Text] [Related]
2. Significance of circulating tumor cells in the portal vein regarding metastases and vascular invasion in hepatocellular carcinoma patients.
Zhao X; Zhao J; Tao L; Pan Y; Yang L; Zhang X; Yuan J; Zhu H
J Gastrointest Oncol; 2021 Dec; 12(6):3050-3060. PubMed ID: 35070429
[TBL] [Abstract][Full Text] [Related]
3. S100P as a novel biomarker of microvascular invasion and portal vein tumor thrombus in hepatocellular carcinoma.
Qi LN; Ma L; Wu FX; Chen YY; Xing WT; Jiang ZJ; Zhong JH; Chen ZS; Gong WF; Ye JZ; Li HH; Shang JJ; Xiang BD; Li LQ
Hepatol Int; 2021 Feb; 15(1):114-126. PubMed ID: 33495903
[TBL] [Abstract][Full Text] [Related]
4. Preoperative circulating tumor cells to predict microvascular invasion and dynamical detection indicate the prognosis of hepatocellular carcinoma.
Zhou J; Zhang Z; Zhou H; Leng C; Hou B; Zhou C; Hu X; Wang J; Chen X
BMC Cancer; 2020 Oct; 20(1):1047. PubMed ID: 33129301
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus infection and active replication promote the formation of vascular invasion in hepatocellular carcinoma.
Wei X; Li N; Li S; Shi J; Guo W; Zheng Y; Cheng S
BMC Cancer; 2017 May; 17(1):304. PubMed ID: 28464845
[TBL] [Abstract][Full Text] [Related]
6. Whole-exome sequencing reveals the metastatic potential of hepatocellular carcinoma from the perspective of tumor and circulating tumor DNA.
Zhou C; Weng J; Liu S; Zhou Q; Hu Z; Yin Y; Lv P; Sun J; Li H; Yi Y; Shen Y; Ye Q; Shi Y; Dong Q; Liu C; Zhu X; Ren N
Hepatol Int; 2023 Dec; 17(6):1461-1476. PubMed ID: 37217808
[TBL] [Abstract][Full Text] [Related]
7. Risk factors of microvascular invasion, portal vein tumor thrombosis and poor post-resectional survival in HBV-related hepatocellular carcinoma.
Zhou L; Rui JA; Wang SB; Chen SG; Qu Q
Hepatogastroenterology; 2014 Sep; 61(134):1696-703. PubMed ID: 25436365
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal circulating tumor cells and Ki67: their mutual correlation and prognostic implications in hepatocellular carcinoma.
Yang X; Ni H; Lu Z; Zhang J; Zhang Q; Ning S; Qi L; Xiang B
BMC Cancer; 2023 Jan; 23(1):10. PubMed ID: 36600214
[TBL] [Abstract][Full Text] [Related]
9. Revisiting Surgical Strategies for Hepatocellular Carcinoma With Microvascular Invasion.
Zhang EL; Cheng Q; Huang ZY; Dong W
Front Oncol; 2021; 11():691354. PubMed ID: 34123861
[TBL] [Abstract][Full Text] [Related]
10. Significance of presence of microvascular invasion in specimens obtained after surgical treatment of hepatocellular carcinoma.
Zhang X; Li J; Shen F; Lau WY
J Gastroenterol Hepatol; 2018 Feb; 33(2):347-354. PubMed ID: 28589639
[TBL] [Abstract][Full Text] [Related]
11. Preoperative evaluation and prediction of clinical scores for hepatocellular carcinoma microvascular invasion: a single-center retrospective analysis.
He YZ; He K; Huang RQ; Wang ZL; Ye SW; Liu LW; Luo QJ; Hu ZM
Ann Hepatol; 2020; 19(6):654-661. PubMed ID: 32768591
[TBL] [Abstract][Full Text] [Related]
12. Clinical analysis of deceased donor liver transplantation in the treatment of hepatocellular carcinoma with segmental portal vein tumor thrombus: A long-term real-world study.
Sha M; Chen C; Shen C; Jeong S; Sun HY; Xu N; Hang HL; Cao J; Tong Y
Front Oncol; 2022; 12():971532. PubMed ID: 36203429
[TBL] [Abstract][Full Text] [Related]
13. Accurate prediction of microvascular invasion occurrence and effective prognostic estimation for patients with hepatocellular carcinoma after radical surgical treatment.
Xiong Y; Cao P; Lei X; Tang W; Ding C; Qi S; Chen G
World J Surg Oncol; 2022 Sep; 20(1):328. PubMed ID: 36180867
[TBL] [Abstract][Full Text] [Related]
14. The influencing factors for tumor thrombus in patients with hepatocellular carcinoma.
Ma J; Li D; Zhu X
J Gastrointest Oncol; 2024 Feb; 15(1):415-424. PubMed ID: 38482224
[TBL] [Abstract][Full Text] [Related]
15. Acute-Phase Serum Amyloid A May Predict Microvascular Invasion and Early Tumor Recurrence in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma Undergoing Liver Resection.
Guo X; Zhang W; Du J; Tao R; Dong W; Huang J; Zhang J; Pan Z; Zhou W; Zhu X; Liu H; Liu F
J Invest Surg; 2022 Jun; 35(6):1368-1376. PubMed ID: 35143736
[TBL] [Abstract][Full Text] [Related]
16. Prognostic potential of preoperative circulating tumor cells to predict the early progression recurrence in hepatocellular carcinoma patients after hepatectomy.
Lu Z; Ni H; Yang X; Tan L; Zhuang H; Mo Y; Wei X; Qi L; Xiang B
BMC Cancer; 2023 Nov; 23(1):1150. PubMed ID: 38012581
[TBL] [Abstract][Full Text] [Related]
17. Potential predictive factors for microvascular invasion in hepatocellular carcinoma classified within the Milan criteria.
Imura S; Teraoku H; Yoshikawa M; Ishikawa D; Yamada S; Saito Y; Iwahashi S; Ikemoto T; Morine Y; Shimada M
Int J Clin Oncol; 2018 Feb; 23(1):98-103. PubMed ID: 28875240
[TBL] [Abstract][Full Text] [Related]
18. Cancer-Associated Fibroblasts Promote Vascular Invasion of Hepatocellular Carcinoma via Downregulating Decorin-integrin β1 Signaling.
Zheng X; Wang P; Li L; Yu J; Yu C; Xu L; Li L; Dai F; Feng L; Zou H; Chen X; Zhang M; Xu M
Front Cell Dev Biol; 2021; 9():678670. PubMed ID: 34504839
[TBL] [Abstract][Full Text] [Related]
19. An Eastern Hepatobiliary Surgery Hospital Microvascular Invasion Scoring System in Predicting Prognosis of Patients with Hepatocellular Carcinoma and Microvascular Invasion After R0 Liver Resection: A Large-Scale, Multicenter Study.
Zhang XP; Wang K; Wei XB; Li LQ; Sun HC; Wen TF; Chai ZT; Chen ZH; Shi J; Guo WX; Xie D; Cong WM; Wu MC; Lau WY; Cheng SQ
Oncologist; 2019 Dec; 24(12):e1476-e1488. PubMed ID: 31138726
[TBL] [Abstract][Full Text] [Related]
20. Postoperative adjuvant treatment strategy for hepatocellular carcinoma with microvascular invasion: a non-randomized interventional clinical study.
Wang L; Wang W; Rong W; Li Z; Wu F; Liu Y; Zheng Y; Zhang K; Siqin T; Liu M; Chen B; Wu J
BMC Cancer; 2020 Jul; 20(1):614. PubMed ID: 32611327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
